TAKESHITA Kaori 竹下香

… Alternative Names

新庄香シンジョウカオリ

Less

Researcher Number	30397393
Affiliation (based on the past Project Information) *help	2009: Hamamatsu University School of Medicine, 保健管理センター, 特任助教 2005 – 2008: 浜松医科大学, 医学部附属病院, 医員
Review Section/Research Field	Principal Investigator Laboratory medicine Except Principal Investigator Laboratory medicine
Keywords	Principal Investigator mpl / 受容体 / 糖鎖 / フローサイトメトリー / ホルモン / carbohydrate chain / flow cytometry / thyrotropin / hormone / receptor … More / cytokine / 造血因子 / フローサトメトリー / 甲状腺刺激ホルモン / サイトカイン / ビオチン化 / TSH … More Except Principal Investigator 白血病細胞 / mRNA / 白血病 / 肝細胞 / Kras / bcr-abl / 癌細胞 / KRAS / FRET法 / 幹細胞 / cell sorter / エネルギー移行 / 生細胞 / Wt-1 / flow cytometry / 微少残存病変 Less

A functional quantitative receptor assay using flluoscein labeled hormones with a carbohydrate chain for the evaluation of the hormonal replacement therapyPrincipal Investigator
- Principal Investigator
  
  ONO Takaaki, 竹下香 (新庄香)
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Laboratory medicine
- Research Institution
  Hamamatsu University School of Medicine
Utility of separation technique of live cancer stem cells with using an energy transfer fluorescence probes
- Principal Investigator
  
  TAKESHITA Akihiro
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Laboratory medicine
- Research Institution
  Hamamatsu University School of Medicine
Identification of minimal residual cells after the treatment of leukemia cells by the imaging of mRNA
- Principal Investigator
  
  TAKESHITA Akihiro
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Laboratory medicine
- Research Institution
  Hamamatsu University School of Medicine
Anon-isotopic quantitative receptor assay using biotinylation of ligands and hormones with a carbohydrate chainPrincipal Investigator
- Principal Investigator
  
  TAKESHITA Kaori
- Project Period (FY)
  2005 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Laboratory medicine
- Research Institution
  Hamamatsu University School of Medicine

All 2011 2010 2009 2008 2007 2005 Other

All Journal Article Presentation Book

[Book] 血液疾患における分子標的治療ドラッグラグ解消に向けて白血病急性前骨髄球性白血病に対するレチノイン酸Am80 最近の進展2010
- Author(s)
  竹下明裕
- Total Pages
  6
- Publisher
  血液フロンティア
- Data Source
  KAKENHI-PROJECT-21590622
[Book] APLにおけるレチノイン酸症候群とケモカイン産生2010
- Author(s)
  竹下明裕
- Total Pages
  5
- Publisher
  血液・腫瘍科
- Data Source
  KAKENHI-PROJECT-21590622
[Book] Annual review2009
- Author(s)
  竹下明裕
- Publisher
  中外医学社
- Data Source
  KAKENHI-PROJECT-19590552
[Book] 腫瘍内科2009
- Author(s)
  竹下明裕, 直江知樹
- Publisher
  科学評論社
- Data Source
  KAKENHI-PROJECT-19590552
[Book] 周産期医学2008
- Author(s)
  竹下明裕
- Publisher
  東京医学社
- Data Source
  KAKENHI-PROJECT-19590552
[Book] medicina2008
- Author(s)
  竹下明裕
- Publisher
  医学書院
- Data Source
  KAKENHI-PROJECT-19590552
[Book] Clinical Significance of P-Glycoprotein in Acute Leukemia and a Strategy to Overcome Drug Resistance
- Author(s)
  Motoji T, Motomura S, Wang Y, Tsuji K, Takanashi M, Shiozaki H, Miyawaki S, Asou N, Takeshita A, Saburi Y, Ohno R, Mizoguchi H
- Publisher
  Frontiers in Cancer Res
- Data Source
  KAKENHI-PROJECT-19590552
[Journal Article] Impact of additional chromosomal abnormalities in patients with acute promyelocytic leukemia : 10-year results of the Japan Adult Leukemia Study Group APL97 study.2011
- Author(s)
  Ono T, Takeshita A, et al
- Journal Title
  
  Haematologica
  
  Volume: 96(1) Pages: 174-176
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590622
[Journal Article] Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia study Group (JALSG)-AML206 study2011
- Author(s)
  Usui N, Ohnishi K, et al
- Journal Title
  
  Cancer Science
  
  Volume: 102(7) Issue: 7 Pages: 1358-65
- DOI
  10.1111/j.1349-7006.2011.01957.x
- NAID
  10029295449
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590621, KAKENHI-PROJECT-21590622, KAKENHI-PROJECT-21591198
[Journal Article] for the Japan Adult Leukemia Study Group. Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia(AML): Japan Adult Leukemia Study Group(JALSG)-AML206 study2011
- Author(s)
  Usui N, Takeshita A, Nakaseko C, Dobashi N, Fujita H, Kiyoi H, Kobayashi Y, Sakura T, Yahagi Y, Shigeno K, Ohwada C, Miyazaki Y, Ohtake S, Miyawaki S, Naoe T, Ohnishi K
- Journal Title
  
  Cancer Sci
  
  Volume: 102 Pages: 1358-1365
- Data Source
  KAKENHI-PROJECT-21590622
[Journal Article] Impact of additional chromosomal abnormalities in patients with acute promyelocytic leukemia : 10-year results of the Japan Adult Leukemia Study Group APL97 study2011
- Author(s)
  Ono T, Takeshita A, et al
- Journal Title
  
  Haematologica
  
  Volume: 96(1) Pages: 174-176
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590621
[Journal Article] MEDICAL TECHNOLOGISTS AT UNIVERSITY HOSPITAL BLOOD TRANSFUSION DEPARTMENTS PLAY AN IMPORTANT ROLE IN EDUCATION IN TRANSFUSION MEDICINE: THE 2009 TRANSFUSION CONFERENCE OF JAPANESE UNIVERSITY HOSPITALS. SURVEILLANCE REPORT ON MEDICAL EDUCATION (1)2011
- Author(s)
  Fujihara H, Takeshita A, et al
- Journal Title
  
  Japanese Journal of Transfusion and Cell Therapy
  
  Volume: 57 Issue: 6 Pages: 470-477
- DOI
  10.3925/jjtc.57.470
- NAID
  130004542649
- ISSN
  1881-3011, 1883-0625
- Language
  Japanese
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590622
[Journal Article] Impact of additional chromosomal abnormalities in patients with acute promyelocytic leukemia : 10-year results of the Japan Adult Leukemia Study Group APL97 study.2011
- Author(s)
  Ono T, Takeshita A, et al
- Journal Title
  
  Haematologica
  
  Volume: 96(1) Pages: 174-176
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590621
[Journal Article] Impact of additional chromosomal abnormalities in patients with acute promyelocytic leukemia : 10-year results of the Japan Adult Leukemia Study Group APL97 study2011
- Author(s)
  Ono T, Takeshita A, et al
- Journal Title
  
  Haematologica
  
  Volume: 96(1) Issue: 1 Pages: 174-6
- DOI
  10.3324/haematol.2010.030205
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590622, KAKENHI-PROJECT-23591396
[Journal Article] Japan Adult Leukemia Study Group. Impact of additional chromosomal abnormalities in patients with acute promyelocytic leukemia : 10-year results of the Japan Adult Leukemia Study Group APL97study2011
- Author(s)
  Ono T, Takeshita A, Iwanaga M, Asou N, Naoe T, Ohno R
- Journal Title
  
  Haematologica
  
  Volume: 96 Pages: 174-176
- Data Source
  KAKENHI-PROJECT-21590622
[Journal Article] Collaborative study of irregular erythrocyte antibodies in Japan : results from the Japanese study group of allo-immunity and antigen diversity in Asian populations.2010
- Author(s)
  Takeshita A, et al
- Journal Title
  
  Transfus Apheresis Sciences
  
  Volume: 43(1) Pages: 3-8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590622
[Journal Article] Collaborative study of irregular erythrocyte antibodies in Japan : results from the Japanese study group of allo-immunity and antigen diversity in Asian populations2010
- Author(s)
  Takeshita A, Watanabe H, Fijihara H, Oshida M, Yurugi K, Tomoda Y, Uchikawa M, Kino S, Ohto H
- Journal Title
  
  Transfus Apher Sci
  
  Volume: 43 Pages: 3-8
- Data Source
  KAKENHI-PROJECT-21590622
[Journal Article] Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute my eloid leukemia : Final results of Japanese multi-center cooperative study2009
- Author(s)
  Kobayashi Y, Naito K, Takeshita A, Morishima Y, Ogura M, Besso H, Hotta T, Mitani K, Takeuchi H, Miyawaki S, Naoe T, Ohno R
- Journal Title
  
  Int J Hematol (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590552
[Journal Article] CMC-544 (inotuzumab ozogamicin) shows less effect on multidrug resistant cells : analyses in cell lines and cells from patients with B-cell chronic lymphocytic leukaemia and lymphoma2009
- Author(s)
  Takeshita A, et al.
- Journal Title
  
  Br J Haematol 146
  
  Pages: 34-43
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590622
[Journal Article] Effective Blood Utilization via System for Massive Blood Transfusion, including Cardiovascular Operation in Local Areas2009
- Author(s)
  Takeshita A, Asai T, Murakami M, Fujihara H, Ishizuka T, Nakai S, Yamada C, Suzumura T, Uchiyama Y, Maekawa M, Shigeno K, Washiyama N, Yamashita K, Unno N, Shinjo K
- Journal Title
  
  Jpn J Transfusion Cell Therapy
  
  Volume: 55(1) Pages: 63-7
- NAID
  10025628900
- Data Source
  KAKENHI-PROJECT-21590622
[Journal Article] CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells2009
- Author(s)
  Takeshita A, et al.
- Journal Title
  
  Leukemia 23
  
  Pages: 1329-1336
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590621
[Journal Article] CMC-544(inotuzumab ozogamicin) shows less effect on multidrug resistant cells : analyses in cell lines and cells from patients with B-cell chronic lymphocytic leukaemia and lymphoma2009
- Author(s)
  Takeshita A, Shinjo K, Yamakage N, Ono T, Hirano I, Matsui H, Shigeno K, Nakamura S, Tobita T, Maekawa M, Ohnishi K, Sugimoto Y, Kiyoi H, Naoe T, Ohno R
- Journal Title
  
  Br J Haematol
  
  Volume: 146(1) Pages: 34-43
- Data Source
  KAKENHI-PROJECT-21590622
[Journal Article] Effective Blood Utilization via System for Massive Blood Transfusion, including Cardiovascular Operation in Local Areas2009
- Author(s)
  Takeshita A, et al.
- Journal Title
  
  Jpn J Transfusion Cell Therapy 55
  
  Pages: 63-7
- NAID
  10025628900
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590622
[Journal Article] CMC-544(inotuzumab ozogamicin) shows less effect on multidrug resistant cells : analyses in cell lines and cells from patients with B-cell chronic lymphocytic leukaemia and lymphoma2009
- Author(s)
  Takeshita A, Ono T, et al
- Journal Title
  
  Br J Haematol
  
  Volume: 136 Pages: 34-43
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590621
[Journal Article] Effective blood utilization via system for massive blood transfusion, including cardiovascular operation in local areas2009
- Author(s)
  Takeshita A, Asai T, Murakami M, Fujihara H, Ishizuka T, Nakai S, Yamada C, Suzumura T, Uchiyama Y, Maekawa M, Shigeno K, Washiyama N, Yamashita K, Unno N, Shinjo K
- Journal Title
  
  Jpn J Transfusion and Cell Therapy 55
  
  Pages: 64-67
- NAID
  10025628900
- Data Source
  KAKENHI-PROJECT-19590552
[Journal Article] CMC-544(inotuzumab ozogamicin), an anti-CD22immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells2009
- Author(s)
  Takeshita A, Yamakage N, Shinjo K, Ono T, Hirano I, Nakamura S, Shigeno K, Tobita T, Maekawa M, Kiyoi H, Naoe T, Ohnishi K, Sugimoto Y, Ohno R
- Journal Title
  
  Leukemia
  
  Volume: 23(7) Pages: 1329-36
- Data Source
  KAKENHI-PROJECT-21590622
[Journal Article] Phase I/II study of humanized anti-CD33antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study2009
- Author(s)
  Kobayashi Y, Tobinai K, Takeshita A, Naito K, Asai O, Dobashi N, Furusawa S, Saito K, Mitani K, Morishima Y, Ogura M, Yoshiba F, Hotta T, Bessho M, Matsuda S, Takeuchi J, Miyawaki S, Naoe T, Usui N, Ohno R
- Journal Title
  
  Int J Hematol
  
  Volume: 89(4) Pages: 460-9
- NAID
  10025161243
- Data Source
  KAKENHI-PROJECT-21590622
[Journal Article] CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells2009
- Author(s)
  Takeshita A, et al.
- Journal Title
  
  Leukemia 23
  
  Pages: 1329-1336
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590622
[Journal Article] CMC-544 (inotuzumab ozogamicin) shows less effect on multidrug resistant cells : analyses in cell lines and cells from patients with B-cell chronic lymphocytic leukemia and lymphoma2009
- Author(s)
  Takeshita A, Shinjo K, Yamakage N, Ono T, Hirano I, Matsui H, Nakamura S, Shigeno K, Tobita T, Maekawa M, Kiyoi H, Naoe T, Ohnishi K, Sugimoto Y, Ohno R
- Journal Title
  
  Br J Hematol (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590552
[Journal Article] Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study2009
- Author(s)
  Kobayashi Y, Takeshita A, et al
- Journal Title
  
  Int J Hematol
  
  Volume: 89 Pages: 460-469
- NAID
  10025161243
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590621
[Journal Article] CMC544 (inotuzumab ocogamicin), an ati-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B- cells2009
- Author(s)
  Takeshita A, Yamakage N, Shinjo K, Ono T, Hirano I, Nakamura S, Shigeno K, Tobita T, Maekawa M, Kiyoi H, Naoe T, Ohnishi K, Sugimoto Y, Ohno R
- Journal Title
  
  Leukemia (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590552
[Journal Article] CMC-544 (inotuzumab ozogamicin) shows less effect on multidrug resistant cells : analyses in cell lines and cells from patients with B-cell chronic lymphocytic leukaemia and lymnhoma2009
- Author(s)
  Takeshita A, et al.
- Journal Title
  
  Br J Haematol 146
  
  Pages: 34-43
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590621
[Journal Article] CMC-544(inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells2009
- Author(s)
  Takeshita A, Ono T, et al
- Journal Title
  
  Leukemia
  
  Volume: 23 Pages: 1329-1336
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590621
[Journal Article] Effective blood utilization via system for massive blood trans fusion, including cardiovascular operation in local areas2009
- Author(s)
  Takeshita A, Asai T, Murakami M, Fujihara H, Ishizuka T, Nakai S, Yamada C, Suzumura T, Uchiyama Y, Maekawa M, Shigeno K, Washiyama N, Yamashita K, Unno N, Shinjo K.
- Journal Title
  
  Jap J Transfusion and Cell Therapy 55
  
  Pages: 64-67
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590552
[Journal Article] Clinical Significance of P-Glycoprotein in Acute Leukemia and a Strategy to Overcome Drug Resistance2007
- Author(s)
  Motoji T, Motomura S, Wang Y, .Tsuji K, Takanashi M, Slvozaki H, Mlyawaki S, Asou N, Takeshita A, Saburi Y, Ohno R, Mizoguchi H
- Journal Title
  
  Frontiers in Cancer Res
  
  Pages: 123-151
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590552
[Journal Article] 造血器腫瘍基礎・臨床領域における最新の研究動向。臨床編診断法細胞表面マーカー(解説/特集〉2007
- Author(s)
  竹下明裕
- Journal Title
  
  日本臨床 65(1)
  
  Pages: 293-298
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590552
[Journal Article] 造血器腫瘍の分子標的療法。標準的治療にみる分子標的療法レチノイン酸、Am80による急性前骨髄球性白血病の治療急性前骨髄球性白1(ll病に対する全トランス型レチノイン酸と合成レチノイド.Am80の標準的な治療と発展性2007
- Author(s)
  竹下明裕
- Journal Title
  
  医学のあゆみ 220(9)
  
  Pages: 681-686
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590552
[Journal Article] Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide2007
- Author(s)
  Fujisawa S, Ohno R, Shigeno K, Sahara N, Nakamura S, Naito K, Kobayashi M, Shinjo K, Takeshita A, Suzuki Y, Hashimoto H, Kinoshita K, Shimoya M, Kaise T, Ohnishi K
- Journal Title
  
  Cancer Chemother Pharmacol 54
  
  Pages: 485-493
- Data Source
  KAKENHI-PROJECT-19590552
[Journal Article] 造血器腫瘍基礎・臨床領域における最新の研究動向。臨床編治療法抗体療法白血病の抗体療法2007
- Author(s)
  竹下明裕
- Journal Title
  
  日本臨床 65(1)
  
  Pages: 408-415
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590552
[Journal Article] A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARa transcript after consolidation therapy:The Japan Adult Leukemia Study Group(JALSG)APL97 study2007
- Author(s)
  Asou N, KIshimoto Y, Kiyoi H, Okada M, Kawai Y, Tsuzuki M, Horikawa K, Matsuda M, Shinagawa K, Ohtake S, Nishimura M, Takahashi M, Yagasaki F, Takeshita A, Kimura Y, Iwanaga M, Naoe T, Ohno R
- Journal Title
  
  Blood 110(1)
  
  Pages: 59-66
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590552
[Journal Article] Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractoryacute promyelocytic leukemia treated with arsenic trioxide2007
- Author(s)
  Fujisawa S, Ohno R, Shigeno K, Sahara N, Nakamura S, Naito K, Kobayashi M, Shinjo K, Takeshita A, Suzuki Y, Hashimoto H, Kinoshita K, Shimoya M, Kaise T, Ohnishi K.
- Journal Title
  
  Cancer Chemother Pharmacol 59(4)
  
  Pages: 485-493
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590552
[Journal Article] Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group(JALSG)2007
- Author(s)
  Miyawaki S, Kawai Y, Takeshita A, Komatsu N, Usui N, Arai Y, Ishida F, Morii T, Kano Y, Ogura M, Doki N, Ohno R
- Journal Title
  
  Int J Heamatol 86
  
  Pages: 343-347
- NAID
  10019990223
- Data Source
  KAKENHI-PROJECT-19590552
[Journal Article] A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARα transcript after consolidation therapy : The Japan Adult Leukemia Study Group(JALSG)APL97 study2007
- Author(s)
  Asou N, KIshimoto Y, Kiyoi H, Okada M, Kawai Y, Tsuzuki M, Horikawa K, Matsuda M, Shinagawa K, Ohtake S, NishimuraM, Takahashi M, Yagasaki F, Takeshita A, Kimura Y, Iwanaga M, Naoe T, Ohno R
- Journal Title
  
  Blood 110
  
  Pages: 59-66
- Data Source
  KAKENHI-PROJECT-19590552
[Journal Article] Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cells2005
- Author(s)
  Takeshita, A., et. al.
- Journal Title
  
  Leukemia 19
  
  Pages: 1306-1311
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17590489
[Journal Article] Two patients with all-trans retinoic acid-resistant acute promyelocytic leukemia treated successfully with gemtuzumab ozogamicin as a single agent2005
- Author(s)
  Takeshita, A., et. al.
- Journal Title
  
  Int J Hematol 82
  
  Pages: 445-448
- NAID
  10016917120
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17590489
[Journal Article] Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cells.2005
- Author(s)
  Takeshita A, et al.
- Journal Title
  
  Leukemia 19(8)
  
  Pages: 1306-1311
- Data Source
  KAKENHI-PROJECT-17590489
[Journal Article] Two patients with all-trans retinoic acid-resistant acute promyelocytic leukemia treated successfully with gemtuzumab ozogamicin as a single agent.2005
- Author(s)
  Takeshita A, et. al.
- Journal Title
  
  Int J Hematol. 82
  
  Pages: 445-448
- NAID
  10016917120
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17590489
[Journal Article] Efficacy of gemtuzumab ozogamicin on ATRA-and arsenic-resistant acute promyelocytic leukemia(APL)cells.2005
- Author(s)
  Takeshita A, et. al.
- Journal Title
  
  Leukemia. 19
  
  Pages: 1306-1311
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17590489
[Journal Article] Education in transfusion medicine for medical students and doctors
- Author(s)
  Takeshita A, Yoneyama Y, Fujihara H, Nollet KE, Ohto H
- Journal Title
  
  Vox Sanguinis
  
  Volume: (in press)
- Data Source
  KAKENHI-PROJECT-21590622
[Journal Article] Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : Final results of Japanese multi-center cooperative study
- Author(s)
  Kobayashi Y, Naito K, Takeshita A, Morishima Y, Ogura M, Besso H, Hotta T, Mitani K, Takeuchi H, Miyawaki S, Naoe T, Ohno R.
- Journal Title
  
  Int J Hematol (in press)
- Data Source
  KAKENHI-PROJECT-19590552
[Journal Article] CMC544(inotuzumab ocogamicin), an ati-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells
- Author(s)
  Takeshita A, Yamakage N, Shinjo K, Ono T, Hirano I, Nakamura S, Shigeno K, Tobita T, Maekawa M, Kiyoi H, Naoe T, Ohnishi K, Sugimoto Y, Ohno R
- Journal Title
  
  Leukemia (in press)
- Data Source
  KAKENHI-PROJECT-19590552
[Journal Article] CMC-544(inotuzumab ozogamicin)shows less effect on multidrug resistant cells : analyses in cell lines and cells from patients with B-cell chronic lymphocytic leukemia and lymphoma
- Author(s)
  Takeshita A, Shinjo K, Yamakage N, Ono T, Hirano I, Matsui H, Nakamura S, Shigeno K, Tobita T, Maekawa M, Kiyoi H, Naoe T, Ohnishi K, Sugimoto Y, Ohno R
- Journal Title
  
  Br J Haematol (in press)
- Data Source
  KAKENHI-PROJECT-19590552
[Presentation] Efficacy of gemtuzumab ozogamicin (GO) on relapsed/refractory acute promyelocytic leukemia (APL)2011
- Author(s)
  Takeshita A, et al
- Organizer
  Annual Meeting of American Society of Hematology
- Place of Presentation
  San Diego, USA
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] Our role in promoting a better understanding of the efficacy of cryoprecipitate in acquired hypofibrinoginemia induced by perioperative massive bleeding2011
- Author(s)
  Yamada C, Fujihara H, Watanabe H, Takeshita A
- Organizer
  International Society of Blood Transfusion
- Place of Presentation
  Lisbon, Portugal
- Year and Date
  2011-06-06
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] Role of hematopoietic stem cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans retinoic acid : a retrospective analysis of the Japan Adult Leukemia Study Group(JALSG) APL97Study2011
- Author(s)
  Fujita H, Asou N, Iwanaga M, Hyo R, Nomura S, Kiyoi H, Okada M, Tsuzuki M, Matsuda M, Yamauchi T, Ohtake S, Izumi T, Nakaseko C, Mitani K, Shinagawa K, Takeshita A, Miyazaki Y, Ohnishi K, Miyawaki S, Naoe T
- Organizer
  53rd Annual Meeting of American Society of Hematology San Diego
- Place of Presentation
  CA, USA
- Year and Date
  2011-12-10
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] Clinical features and prognostic impact of CD56 expression in acute promyelocytic leukemia : Long term follow up data from the Japan Adult Leukemia Study Group(JALSG) APL972011
- Author(s)
  Ono T, Takeshita A, et al
- Organizer
  53nd ASH Annual Meeting and Exposition
- Place of Presentation
  San Diego Convention Center, San Diego, U. S. A
- Year and Date
  2011-12-12
- Data Source
  KAKENHI-PROJECT-21590621
[Presentation] Allo-Immunity to Erythrocytes in Relation to Blood Transfusion and Pregnancy ; Report from the Asian Cooperative Group2011
- Author(s)
  Takeshita A
- Organizer
  30^<th> Annual Meeting of Korean Society of Blood Transfusion
- Place of Presentation
  Busan, Korea
- Year and Date
  2011-06-09
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] Clinical impact of CD56 expression in APL ; Results from the Japan Adult Leukemia Study Group APL972011
- Author(s)
  Ono T, Takeshita A, et al
- Organizer
  73^<rd> Annual Meeting of the Japanese Society of Hematology
- Place of Presentation
  Nagoya, Japan
- Year and Date
  2011-10-14
- Data Source
  KAKENHI-PROJECT-21590621
[Presentation] Differences in allo-immunity to erythrocytes between Korea and Japan. Cooperative international study of alloimmunity to antigen diversity in Asian population2011
- Author(s)
  Fujihara H, Takeshita A, Kim DW, Han KS, Kwon SY, Kwon SW, Suh JS, Watanabe H, Uchikawa M, Kino S, Nollet KE, Ohto H
- Organizer
  53rd Annual Meeting of American Society of Hematology San Diego
- Place of Presentation
  CA, USA
- Year and Date
  2011-12-10
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] Clinical features and prognostic impact of CD56expression in acute promyelocytic leukemia : Long term follow up data from the Japan Adult Leukemia Study Group(JALSG) APL972011
- Author(s)
  Ono T, Takeshita A, Kishimoto Y, Kiyoi H, Okada M, Yamauchi T, Tsuzuki M, Horikawa K, Matsuda M, Shinagawa K, Monma F, Ohtake S, Nakaseko C, Takahashi M, Yagasaki F, Kimura Y, Fujita H, Iwanaga M, Asou N, Ohnishi K, Naoe T
- Organizer
  53rd Annual Meeting of American Society of Hematology San Diego
- Place of Presentation
  CA, USA
- Year and Date
  2011-12-10
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] Clinical impact of CD56 expression in APL ; Results from the Japan Adult Leukemia Study Group APL972011
- Author(s)
  小野孝明、竹下明裕
- Organizer
  日本血液学会総会
- Place of Presentation
  名古屋国際会議場
- Year and Date
  2011-10-14
- Data Source
  KAKENHI-PROJECT-21590621
[Presentation] Allo-Immunity to Erythrocytes in Relation to Blood Transfusion and Pregnancy ; Report from the Asian Cooperative Group2011
- Author(s)
  Takeshita A, et al
- Organizer
  30^<th> Annual Meeting of Korean Society of Blood Transfusion
- Place of Presentation
  Busa, Korea
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] The usefulness and demerit of the expected elevation value of serum albumin before replacement therapy2011
- Author(s)
  Fujihara H, Yamada C, Watanabe H, Shibata H, Funai Y, Suzumura T, Kaneko M, Uchiyama S, Takeshita A
- Organizer
  16th Congress of the European Hematology Association
- Place of Presentation
  London, UK
- Year and Date
  2011-06-09
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] Efficacy of gemtuzumab ozogamicin(GO) on relapsed/refractory acute promyelocytic leukemia(APL)2011
- Author(s)
  Takeshita A, Ono T, Kojima Y, Kyo T, Asou N, Suzushima H, Yagasaki H, Maeda T, Okada M, Nakaseko C, Kanbayashi H, Yamaguchi M, Kurosawa M, Tsuboi K, Yjiri T, Nanya Y, UikeN, Akiyama N, Fukuda T, Karimata K, Okumura H, Eto T, Izumiyama K, Watanabe A, Aotsuka N, Ito K, Ozaki K, Naoe T
- Organizer
  53rd Annual Meeting of American Society of Hematology San Diego
- Place of Presentation
  CA, USA
- Year and Date
  2011-12-10
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] Clinical features and prognostic impact of CD56 expression in acute promyelocytic leukemia : Long term follow up data from the Japan Adult Leukemia Study Group (JALSG) APL972011
- Author(s)
  Ono T, Takeshita A, et al
- Organizer
  American Society of Hematology (ASH) Annual Meeting and Exposition (53nd)
- Place of Presentation
  San Diego, CA, San Diego Convention Center
- Year and Date
  2011-12-12
- Data Source
  KAKENHI-PROJECT-21590621
[Presentation] Clinical features and outcomes in elderly patients with acute promyelocytic leukemia-the Japan Adult Leukemia Study Group APL97 study-2010
- Author(s)
  Ono T, Takeshita A, et al
- Organizer
  52nd ASH Annual Meeting and Exposition
- Place of Presentation
  Orange County Convention Center, Orlando, USA
- Year and Date
  2010-12-04
- Data Source
  KAKENHI-PROJECT-21590621
[Presentation] Erythrocyte alloimmunization analyzed by gender and transfusion status2010
- Author(s)
  Takeshita A, Watanabe H, Fujihara H, Oshida M, Yurugi K, Tomoda Y, Uchikawa M, Kino S, Nollet KE, Ohto H
- Organizer
  52nd American Society
- Place of Presentation
  Orland, FL, USA
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] Impact of additional chromosomal abnormalities (ACAs) in patients of acute promyelocytic leukemia 10 years follow up results of the Japan Adult Leukemia Study Group APL97 study2010
- Author(s)
  Ono T, Takeshita A, et al
- Organizer
  15^<th> Congress of the European Hematology Association
- Place of Presentation
  Barcelona, Spain, Fira Barcelona Gran Via Conference Center
- Year and Date
  2010-06-12
- Data Source
  KAKENHI-PROJECT-21590621
[Presentation] Results of the multi-institutional surveys for the 21st Transfusion Conference of Japanese University Hospitals2010
- Author(s)
  Fujihara H, Takeshita A, Watanabe H, Suzumura T, Oshida M, Yurugi K, Tomoda Y, Ohto H
- Organizer
  the AABB Annual Meeting and CTTXPO
- Place of Presentation
  Baltimore, Maryland, USA
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] Clinical Features and Outcomes of Elderly Patients with Acute Promyelocytic Leukemia(APL)-the Japan Adult Leukemia Study Group APL97Study2010
- Author(s)
  Ono T, Takeshita A, Kishimoto Y, Kiyoi H, Okada M, Kawai Y, Tsuzuki M, Horikawa K, Matsuda M, Shinagawa K, Monma F, Ohtake S, Nakaseko C, Takahashi M, Yagasaki F, Kimura Y, Iwanaga M, Asou N, Naoe T, Ohno R
- Organizer
  52nd annual meeting of American Society of Hematology
- Place of Presentation
  Orland, FL, USA
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] Clinical features and outcomes in elderly patients with acute promyelocytic leukemia -the Japan Adult Leukemia Study Group APL97 study-2010
- Author(s)
  Ono T, Takeshita A, et al
- Organizer
  American Society of Hematology (ASH) Annual Meeting and Exposition (52nd)
- Place of Presentation
  Orlando, Florida, Orange County Convention Center
- Year and Date
  2010-12-04
- Data Source
  KAKENHI-PROJECT-21590621
[Presentation] Impact of additional chromosomal abnormalities(ACAs) in patients of acute promyelocytic leukemia10years follow up results of the Japan Adult Leukemia Study Group APL97study2010
- Author(s)
  Ono T, Takeshita A, Kishimoto Y, Kiyoi H, Okada M, Kawai Y, Tsuzuki M, Horikawa K, Matsuda M, Shinagawa K, Monma F, Ohtake S, Nakaseko C, Takahashi M, Yagasaki F, Kimura Y, Iwanaga M, Asou N, Naoe T, Ohno R
- Organizer
  15th Congress of the European Hematology Association
- Place of Presentation
  Barcelona, Spain
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] Clinical features and outcomes in elderly patients with acute promyelocytic leukemia -the Japan Adult Leukemia Study Group APL97 study-2010
- Author(s)
  Ono T, Takeshita A, et al
- Organizer
  American Society of Hematology (ASH) Annual Meeting and Exposition (52nd)
- Place of Presentation
  Orange County Convention Center, Orlando, Florida
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] Erythrocyte allo-immunization analyzed by gender and transfusion status2010
- Author(s)
  Takeshita A, et al
- Organizer
  52^<nd> Annual Meeting of American Society of Hematology
- Place of Presentation
  Orange County Convention Center, Orland, Florida
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] Impact of additional chromosomal abnormalities(ACAs) in patients of acute promyelocytic leukemia 10 years follow up results of the Japan Adult Leukemia Study Group APL97 study2010
- Author(s)
  Ono T, Takeshita A, et al
- Organizer
  15^<th> Congress of the European Hematology Association
- Place of Presentation
  Fira Barcelona Gran Via Conference Center, Barcelona, Spain
- Year and Date
  2010-06-12
- Data Source
  KAKENHI-PROJECT-21590621
[Presentation] Collaborative Study Group of Allo-immunity to Antigen Diversity in Asian Populations. Allo-immunity to erythrocytes in relation to blood transfusion and pregnancy ; Cooperative study of allo-immunity to antigen diversity in Asian populations2009
- Author(s)
  Takeshita A, Watanabe H, Kim DW, Han KS, Kwon SY, Suh JS, Natalie CPH, Nadarajan VS, Permpikul P, Nuranissa Bte Yacob Marican NBY, Uchikawa M, Kino S, Ohto H
- Organizer
  51st Annual Meeting of the American Society of Hematology
- Place of Presentation
  Orleans, LA, USA
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] Collaborative Study Group of Allo-immunity to Antigen Diversity in Asian Populations : Differences in allo-immunity to erythrocytes in Asian countries ; Cooperative study of allo-immunity to antigen diversity in Asian populations2009
- Author(s)
  Watanabe H, Takeshita A, Kim DW, Han KS, Kwon SY, Suh JS, Natalie CPH, Nadarajan VS, Permpikul P, Nuranissa Bte Yacob Marican NBY, Uchikawa M, Kino S, Ohto H
- Organizer
  51st Annual Meeting of the American Society of Hematology
- Place of Presentation
  New Orleans, LA, USA
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] Internalization speed may be one of the factors in the efficacy of CMC-544(inotuzumab ozogamicin), the newly developed calicheamicin-conjugated antibody2009
- Author(s)
  Takeshita A, Shinjo K, Watanabe Y, Maekawa M, Ohnishi K, Sugimoto Y, Ohno R
- Organizer
  68th Annual Meeting of Japanese Cancer Society
- Place of Presentation
  Yokohama
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] Internalization may be important in the efficacy of CMC-544, a new calicheamicin-conjugated anti-CD22 antibody2009
- Author(s)
  Takeshita A, et al
- Organizer
  68^<th> Annual Meeting of the Japanese Cancer Assosiation
- Place of Presentation
  Yokohama, Japan
- Year and Date
  2009-10-02
- Data Source
  KAKENHI-PROJECT-21590621
[Presentation] Collaborative Study Group of Allo-immunity to Antigen Diversity in Asian Populations. Differences in allo-immunity to erythrocytes in Asian countries ; Cooperative study of allo-immunity to antigen diversity in Asian populations2009
- Author(s)
  Watanabe H, Takeshita A, Kim DW, Han KS, Kwon SY, Suh JS, Natalie CPH, Nadarajan VS, Permpikul P, Nuranissa Bte Yacob Marican NBY, Uchikawa M, Kino S, Ohto H
- Organizer
  51st Annual Meeting of the American Society of Hematology
- Place of Presentation
  New Orleans, LA, USA
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] The role of medical technologists on the education of transfusion medicine : Results of the multi-institutional surveys for the 21th Transfusion Conference of University Hospitals in Japan2009
- Author(s)
  Watanabe H, Takeshita A, Oshida M, Fujihara H, Tomoda Y, Yurugi K Ohto H
- Organizer
  20th Congress of International Society of Blood Transfusion
- Place of Presentation
  Nagoya
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] CMC-544, an anti-CD22 immuno-conjugate of calicheamicin, decreases the level of compliment inhibitory factors on malignant B-cell lymphoma cells2009
- Author(s)
  Takeshita A, et al.
- Organizer
  14^<th> congress of European Society of Hematology
- Place of Presentation
  Berlin, Germany
- Year and Date
  2009-06-07
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] Collaborative study on erythrocyte irregular antibodies in Japan Results from Japanese Study Group of Allo-Immunity to Antigen Diversity in Asian populations2009
- Author(s)
  Takeshita A, et al.
- Organizer
  20^<th> Congress of International Society of Blood Transfusion
- Place of Presentation
  Nagoya, Japan
- Year and Date
  2009-11-15
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] Internalization may be important in the efficacy of CMC-544, a new calicheamicin-conjugated anti-CD22 antibody2009
- Author(s)
  Takeshita A, et al.
- Organizer
  68^<th> Annual Meeting of the Japanese Cancer Association
- Place of Presentation
  Yokohama, Japan
- Year and Date
  2009-10-02
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] CMC-544, an anti-CD22immunoconjugate of calicheamicin, decreases the level of compliment inhibitory factors on malignant B-cell lymphoma cells2009
- Author(s)
  Takeshita A, Yamakage N, Shinjo K, Hirano I, Ono T, Fujihara H, Watanabe H, Iino K, Hashimoto D, Maekawa M, Ohnishi K, Ohno R
- Organizer
  14nd Congress of European Society of Hematology
- Place of Presentation
  Berlin, Germany
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] Collaborative study on erythrocyte irregular antibodies in Japan Results from Japanese Study Group of Allo-Immunity to Antigen Diversity in Asian populations2009
- Author(s)
  Takeshita A, Watanabe H, Oshida M, Yurugi K, Tomoda Y, Uchikawa M, Kino S, Ohto H
- Organizer
  20th Congress of International Society of Blood Transfusion
- Place of Presentation
  Nagoya
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] A Phase I/II Trial of Gemtuzumab Ozogamicin in Combination with Cytarabine and Anthracyclines(Daunorubicin or Idarubicin) for CD33-Positive Refractory or Relapsed AML Patients Younger Than65Years. Results of Phase I Parts of the JALSG-AML206Study2009
- Author(s)
  Usui N, Takeshita A, Nakaseko C, Dobashi N, Fujita H, Kiyoi H, Kobayashi Y, Fujisawa S, Yagasaki F, Nishii K, Kiguchi T, Miyazaki Y, Ohtake S, Miyawaki S, Ohno R, Naoe T, Ohnishi K
- Organizer
  51st Annual Meeting of the American Society of Hematology
- Place of Presentation
  New Orleans, LA, USA
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] Collaborative Study Group of Allo-immunity to Antigen Diversity in Asian Populations. Allo-immunity to erythrocytes in relation to blood transfusion and pregnancy ; Cooperative study of allo-immunity to antigen diversity in Asian populations2009
- Author(s)
  Takeshita A, et al.
- Organizer
  51th Annual Meeting of the American Society of Hematology
- Place of Presentation
  New Orleans, USA
- Year and Date
  2009-12-07
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] The role of medical technologists on the education of transfusion medicine : Results of the multi-institutional surveys for the21th Transfusion Conference of University Hospitals in Japan2009
- Author(s)
  Watanabe H, Takeshita A, Oshida M, Fujihara H, Tomoda Y, Yurugi K Ohto H
- Organizer
  20th Congress of International Society of Blood Transfusion
- Place of Presentation
  Nagoya
- Data Source
  KAKENHI-PROJECT-21590622
[Presentation] A Randomized Trial Comparing Individualized Vs. Non-Individualized Treatment for Elderly Acute Myeloid Leukemia : JALSG GML200 study2008
- Author(s)
  Wakita A, Ohtake S, Takada S, Yagasaki F, Komatsu H, Miya zaki Y, Kubo K, Kimura Y, Takeshita A, Adachi Y, Kiyoi H, Yamaguchi T, Yoshida M, Ohnishi K, Miyawaki S, Naoe T, Ueda R, Ohno R
- Organizer
  American Society of Hematology
- Place of Presentation
  Sanfrancisco, USA
- Year and Date
  2008-10-05
- Data Source
  KAKENHI-PROJECT-19590552
[Presentation] The usefulness of the expected elevation value of serum albumin before replacement therapy2008
- Author(s)
  Fujihara H, Takeshita K, Nakai S, Yamada C, Suzumura T, Uchiyama S, Takeshita A
- Organizer
  American Association of Blood Banking
- Place of Presentation
  Montreal, Canada
- Year and Date
  2008-05-10
- Data Source
  KAKENHI-PROJECT-19590552
[Presentation] Cytotoxic effect and drug resistance of calicheamicin transported by permeation,internalization and endocytosis.(カリケアマイシンの細胞内輸送経路による殺細胞作用と薬剤耐性への影響。)2007
- Author(s)
  竹下明裕
- Organizer
  第66回日本癌学会総会
- Place of Presentation
  横浜
- Year and Date
  2007-10-03
- Data Source
  KAKENHI-PROJECT-17590489
[Presentation] Reduc ed effect of CMC544 on P-glycoprotein po sitive malignant B cells and its restoration by multidrug resistance modifiers2007
- Author(s)
  Takeshita A, Shinjo K, YamakageN, O no T, Hirano I, Okinaka K, Matsui H, Nakamura S, Shigeno K, Maekawa M, Ohnishi K , Sugimoto Y , Ohno R
- Organizer
  Annual Meeting of American Society of Hematology, Sanfrancisco, USA
- Place of Presentation
  Atranta, USA, Dec
- Data Source
  KAKENHI-PROJECT-19590552
[Presentation] Reduced effect of inotuzumab ozogamicin(CMC544)on P-glycoprotein positive malignant B cells and its restoration by multidrug resistance modifiers2007
- Author(s)
  Takeshita Akihiro
- Organizer
  The American Society of Hematology 49th Annual Meeting
- Place of Presentation
  USA
- Year and Date
  2007-12-09
- Data Source
  KAKENHI-PROJECT-17590489
[Presentation] Cell cycle features and quantitative alteration of target molecules of malignant B cells treated with CMC544 alone or in combination with rituximab2007
- Author(s)
  Yamakage N, Takeshita A, Shinjo K, Ono T, Hiranol, Okinaka K, Nakamura S, Shigeno K, Maekawa M, Ohnishi K, Ohno R
- Organizer
  American Society of Hematology
- Place of Presentation
  アトランタ(米国)
- Year and Date
  2007-12-09
- Data Source
  KAKENHI-PROJECT-19590552
[Presentation] Cytotoxic effect and drug resistance of calicheamicin transported by permeation, internaHzation and endocytosis.(カリケアマイシンの細胞内輸送経路による殺細胞作用と薬剤耐性への影響.)2007
- Author(s)
  竹下明裕, 他
- Organizer
  第66回日本癌学会総会
- Place of Presentation
  横浜
- Year and Date
  2007-10-03
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17590489
[Presentation] Reduced effect of inotuzumab ozogamicin(CMC544)on P-glycoprotein positive malignant B cells and its restoration by multidrug resistance modifiers.2007
- Author(s)
  Takeshita A, et. al.
- Organizer
  The American Society of Hematology 49th Annual Meeting
- Place of Presentation
  USA
- Year and Date
  2007-12-09
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17590489
[Presentation] Cytotoxic effect and drug resistance of calicheamicin transported by permeation, internalization and endocytosis2007
- Author(s)
  Takeshita, A., et. al.
- Organizer
  66th Annual Meeting of the Japanese Cancer Association
- Place of Presentation
  Yokohama
- Year and Date
  2007-10-03
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17590489
[Presentation] Reduced effect of CMC544 on P-glycoprotein positive malignant B cells and its restoration by multidrug resistance modifiers2007
- Author(s)
  Takeshita A, Shinjo K, Yamakage N Ono T, Hiranol, Okinaka K, Matsui H, Nakamura S, Shigeno K, Maekawa M, Ohnishi K, Sugimoto Y, Ohno R
- Organizer
  American Society of Hematology
- Place of Presentation
  アトランタ(米国)
- Year and Date
  2007-12-09
- Data Source
  KAKENHI-PROJECT-19590552
[Presentation] Reduced effect of inotuzumab ozogamicin (CMC544) on P-glycoprotein positive malignant B cells and its restoration by multidrug resistance modifiers2007
- Author(s)
  Takeshita, A., et. al.
- Organizer
  The American Society of Hematology 49th Annual Meeting
- Place of Presentation
  USA
- Year and Date
  2007-12-09
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17590489
[Presentation] Cell cycle features and quantitative alteration of target molecules of malignant B cells treated with CMC544 alone or in combination with rituximab2007
- Author(s)
  Yamakage N, Takeshita A, ShinjoK, Ono T, Hirano I, Okinaka K, Nakamura S, Shigeno K, Maekawa M, Ohnishi K, Ohno R
- Organizer
  Annual Meeting of American Society of Hematology, Sanfrancisco, USA
- Place of Presentation
  Atranta, USA, Dec
- Data Source
  KAKENHI-PROJECT-19590552
[Presentation] 急性前骨髄球性白血病再発例に対するgemtuzumab ozogamicin(Mylotarg)の使用経験.2005
- Author(s)
  新庄香, 他
- Organizer
  第67回日本血液学会・第47回日本臨床血液学会総会
- Place of Presentation
  横浜
- Year and Date
  2005-09-18
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17590489
[Presentation] A Randomized Trial Comparing Individualized Vs. Non-Individualized Treatment for Elderly Acute Myeloid Leukemia : JALSG GML200 Study
- Author(s)
  Wakita A, Ohtake S, Takada S, Yagasaki F, Komatsu H, Miyazaki Y, Kubo K, Kimura Y, Takeshita A, Adachi Y, Kiyoi H, Yamaguchi T, Yoshida M, Ohnishi K, Miyawaki S, Naoe T, Ueda R, Ohno R.
- Organizer
  Annual Meeting of American Society of Hematology
- Place of Presentation
  Sanfrancisco, USA
- Data Source
  KAKENHI-PROJECT-19590552
[Presentation] The usefulness of the expected elevation value of serum albumin before replacement therapy
- Author(s)
  Fujihara H, Takeshita K, Nakai S, Yamada C, Suzumura T, Uchiyama S, Takeshita A.
- Organizer
  Annual Meeting of AABB Montreal
- Place of Presentation
  Canada
- Data Source
  KAKENHI-PROJECT-19590552

1. TAKESHITA Akihiro (00242769)

# of Collaborated Projects: 4 results

# of Collaborated Products: 101 results
2. OHNISHI Kazunori (80252170)

# of Collaborated Projects: 3 results

# of Collaborated Products: 9 results
3. MAEKAWA Masato (20190291)

# of Collaborated Projects: 2 results

# of Collaborated Products: 10 results
4. ONO Takaaki (40402276)

# of Collaborated Projects: 2 results

# of Collaborated Products: 12 results

TAKESHITA Kaori 竹下 香

新庄 香 シンジョウ カオリ

Research Projects

Research Products

Co-Researchers

A functional quantitative receptor assay using flluoscein labeled hormones with a carbohydrate chain for the evaluation of the hormonal replacement therapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Utility of separation technique of live cancer stem cells with using an energy transfer fluorescence probes

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Identification of minimal residual cells after the treatment of leukemia cells by the imaging of mRNA

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Anon-isotopic quantitative receptor assay using biotinylation of ligands and hormones with a carbohydrate chainPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 血液疾患における分子標的治療 ドラッグラグ解消に向けて 白血病急性前骨髄球性白血病に対するレチノイン酸Am80 最近の進展2010

Author(s)

Total Pages

Publisher

Data Source

[Book] APLにおけるレチノイン酸症候群とケモカイン産生2010

Author(s)

Total Pages

Publisher

Data Source

[Book] Annual review2009

Author(s)

Publisher

Data Source

[Book] 腫瘍内科2009

Author(s)

Publisher

Data Source

[Book] 周産期医学2008

Author(s)

Publisher

Data Source

[Book] medicina2008

Author(s)

Publisher

Data Source

[Book] Clinical Significance of P-Glycoprotein in Acute Leukemia and a Strategy to Overcome Drug Resistance

Author(s)

Publisher

Data Source

[Journal Article] Impact of additional chromosomal abnormalities in patients with acute promyelocytic leukemia : 10-year results of the Japan Adult Leukemia Study Group APL97 study.2011

Author(s)

Journal Title

Data Source

[Journal Article] Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia study Group (JALSG)-AML206 study2011

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] for the Japan Adult Leukemia Study Group. Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia(AML): Japan Adult Leukemia Study Group(JALSG)-AML206 study2011

Author(s)

Journal Title

Data Source

[Journal Article] Impact of additional chromosomal abnormalities in patients with acute promyelocytic leukemia : 10-year results of the Japan Adult Leukemia Study Group APL97 study2011

Author(s)

Journal Title

Data Source

[Journal Article] MEDICAL TECHNOLOGISTS AT UNIVERSITY HOSPITAL BLOOD TRANSFUSION DEPARTMENTS PLAY AN IMPORTANT ROLE IN EDUCATION IN TRANSFUSION MEDICINE: THE 2009 TRANSFUSION CONFERENCE OF JAPANESE UNIVERSITY HOSPITALS. SURVEILLANCE REPORT ON MEDICAL EDUCATION (1)2011

Author(s)

Journal Title

TAKESHITA Kaori 竹下香

新庄香シンジョウカオリ

[Book] 血液疾患における分子標的治療ドラッグラグ解消に向けて白血病急性前骨髄球性白血病に対するレチノイン酸Am80 最近の進展2010